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Abstract
Follicular helper T (Tfh) cells within secondary lymphoid organs control multiple steps of B
cell maturation and antibody (Ab) production. HIV-1 infection is associated with an altered B
cell differentiation and Tfh isolated from lymph nodes of HIV-infected (HIV+) individuals pro-
vide inadequate B cell help in vitro. However, the mechanisms underlying this impairment of
Tfh function are not fully defined. Using a unique collection of splenocytes, we compared
the frequency, phenotype and transcriptome of Tfh subsets in spleens from HIV negative
(HIV-) and HIV+ subjects. We observed an increase of CXCR5+PD-1highCD57-Tfh and ger-
minal center (GC) CD57+ Tfh in HIV+ spleens. Both subsets showed a reduced mRNA
expression of the transcription factor STAT-3, co-stimulatory, regulatory and signal trans-
duction molecules as compared to HIV- spleens. Similarly, Foxp3 expressing follicular regu-
latory T (Tfr) cells were increased, suggesting sustained GC reactions in chronically HIV+
spleens. As a consequence, GC B cell populations were expanded, however, complete
maturation into memory B cells was reduced in HIV+ spleens where we evidenced a
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our data indicate that, although Tfh proliferation and GC reactions seem to be ongoing in
HIV-infected spleens, Tfh “differentiation” and expression of costimulatory molecules is
skewed with a profound effect on B cell maturation.
Introduction
T follicular helper cells (Tfh) are a specialized subset of CD4 T cells that support the multiple
steps of B cell maturation and differentiation into long-lived plasma cells. Tfh cells are charac-
terized by the expression of the chemokine (C-X-C motif) receptor (CXCR) 5 that allows their
migration towards the chemokine (C-X-C motif) ligand (CXCL) 13, a chemokine strongly
expressed in the follicles of the spleen, lymph nodes, and Peyer’s Patches. In these follicles, Tfh
cells provide cognate help to B cells, promoting germinal center (GC) B cell responses and
long-term protective humoral immunity. Tfh cells are characterized by a very high expression
of co-stimulatory molecules involved in B help such as Inducible T-cell Costimulator (ICOS),
OX40 and CD40 ligand (CD40L) [1]. They also express high levels of Programmed Death-1
(PD-1). One functional feature of Tfh cells is their high capacity to secrete Interleukin-21 (IL-
21) and IL-4, which are necessary for GC formation and B cell differentiation into long-lived
plasma cells, respectively [2,3]. In addition to the lineage-specific transcriptional regulator B
cell lymphoma-6 (Bcl6), transcription factor achaete-scute homologue 2 (ASCL2) is selectively
upregulated in Tfh cells and initiates their development [4]. Tfh cell differentiation may be
driven by ICOS [5] and CD28 [6] signals during the priming by dendritic cells (DCs) of CD4 T
cells into Tfh and during Tfh expansion, particularly in response to infection. After priming,
membrane expression of chemokine receptors CCR7 is down-regulated while CXCR5 is up-
regulated thus allowing Tfh cells to migrate towards the follicle. The first antigen specific inter-
action between Tfh and B cells takes place at the T/B border in secondary lymphoid organs.
The second interaction occurs within the germinal center between GCTfh and GC B cells.
CD40L/CD40, OX40/OX40L, Signaling Lymphocyte Activation Molecule (SLAM) family
members and adhesion molecules that strengthen GCTfh / GC B cell interaction are required
for full B cell maturation. These interactions activate B cell somatic hyper-mutation of Ig vari-
able regions and selection of high-affinity B cells. Of note, GCTfh cell maintenance requires
sustained antigenic stimulation by GC B cells. Thus Tfh and GC B cell numbers are closely
interrelated [7].
Recently, T follicular regulatory cells (Tfr) have been described as the regulatory counterpart
of the Tfh population [8–11]. Tfr most probably derive from natural T regulatory cells that up-
regulate Bcl6 and migrate into follicles after up-regulation of CXCR5 and PD-1 [9]. Hence, Tfr
cells share features with both conventional Treg cells and Tfh cells. Similarly to Tregs, they
express the typical markers Forkhead Box P3 (Foxp3) and CTLA-4. Tfr also produce high
amounts of IL-10 and control the GC reaction to prevent the emergence of autoantibodies [9–
12].
In lymph nodes, Tfh cells expand during the chronic phase of HIV infection [13,14]. The
expansion of Tfh cells is highly associated with the viremia, along with increased GC B cell and
plasma cell populations [14]. Similarly, in the non-human primate model of SIV-infection, Tfh
accumulation is associated with increased frequency of GC B cells and SIV-specific antibodies
[15,16]. Interestingly, when cocultured in vitro with autologous B cells, Tfh cells from HIV-
infected subjects fail to provide adequate B cell help, which may be related to the increased
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PD-L1 expression on B cells [17]. Tfh cells are also targets of HIV infection, replication and
production [13]. Regarding humoral responses, HIV infection impairs B cell maturation caus-
ing a loss of memory B cells and an expansion of plasma cells [14,17–19]. It should be noted
that most of these studies were restricted to lymph nodes.
Because spleen is the largest lymphoid organ and the place where immune responses against
blood-borne pathogens are elicited, we decided to characterize splenic Tfh cell populations of
HIV-infected individuals. During the 90s, before introduction of Highly Active Antiretroviral
Therapy (HAART), Autran and colleagues collected spleen samples from HIV- donors and
untreated HIV-1+ individuals [20–24]. At that time, immune thrombocytopenic purpura (ITP)
was a frequent complication of HIV infection. To resolve thrombocytopenia, splenectomy was
proposed as treatment for HIV+ patients who did not respond to standard therapy [25]. Studies
of such clinical specimens led to important breakthroughs in the comprehension of HIV inter-
ference with immune system. One of the most important work performed on HIV-infected
white pulps revealed for the first time, that infected CD4 T cells are present in lymphoid area
where they might be eliminated by HIV-specific cytotoxic T lymphocytes infiltrated in the
spleen [24]. Indeed, a topological study of the CTL response showed that HIV specific cytotoxic
T lymphocytes (CTL) co-localize with HIV-producing cells in germinal centers [26], suggesting
an efficient CD8 priming in vivo. In line with this, antiviral CTL immune responses directed
against Nef protein have been evidenced [27]. Taking advantage of this unique collection of
splenocytes, we performed an extensive characterization of splenic Tfh and B cells from HIV+
and HIV- individuals.
Here, we uncover that Tfh, GCTfh and Tfr cells from the spleen of HIV-infected patients
are expanded as compared to those of uninfected individuals. However, chronic HIV-infection
severely impacts the transcription profiles of splenic Tfh and GCTfh, particularly affecting the
expression of genes implicated in costimulation, inhibition and signal transductions. We show
that splenocytes from HIV+ individuals fail to produce IL-10 and IL-4 that are of particular
importance for B cell maturation and the regulation of GC reaction. As a putative consequence
of Tfh and Tfr dysfunctions, we evidenced a skewed B cell maturation towards an expansion of
GC B cells population at the cost of memory B cells in HIV+ spleens.
Materials and Methods
Samples
Spleens were obtained from organ transplant donors or from patients requiring therapeutic
splenectomy. The spleen collection consists of 4 groups: HIV negative Immune Thrombocyto-
penic Purpura negative (HIV-ITP-) (n = 9), HIV+ITP- (n = 8), HIV-ITP+ (n = 4), HIV+ITP+
(n = 10). All spleen samples included in this study were collected following national ethical
guidelines regulating the use of human tissues and have already been described in previous
studies: HIV-ITP- [28], HIV+ITP- [29,30], HIV-ITP+ [31], HIV+ITP+ [23,26]. Note that HIV
+ spleens were isolated from individuals classified in chronic stage (from middle to late stage)
of HIV infection and who did not receive any HAART [31].
Ethics statement
All samples included in this study were collected following national ethical guidelines regulat-
ing the use of human tissues. All adult subjects provided informed consent, and a parent or
guardian of any child participant provided written informed consent on their behalf. Patient
samples were collected according to French Ethical rules. Written informed consent and
approval by Institutional Review Board at the Pitié-Salpêtrière Hospital were obtained for this
study.
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Splenocytes stimulation
Splenocytes from HIV-ITP- (n = 4), HIV+ITP- (n = 4), HIV-ITP+ (n = 3), HIV+ITP+ (n = 5)
were cultured at 37°C in 6 well plates at a concentration of 1 X 106 cells/mL in complete RPMI
medium containing 10% FBS containing IL-2 (0.2U/mL), Penicillin/streptomycin (Gibco) and
when stated were activated for two days using PHA (PAA) (1μg/mL).
IL-10, IL-6, IL-1ß, IL-4 concentrations were evaluated in supernatants from PHA stimu-
lated splenocytes by Cytometric Beads Array high sensitivity assay according to the manufac-
turer protocol (BD Biosciences).
Flow cytometry
Antibodies. Directly conjugated antibodies were purchased from BD Biosciences (San
Jose, CA, USA): CCR7-PECy7 (3D12), CD3-PerCPCy5.5 and CD3-V500 (UCHT1), Fox-
p3-AF488 (259D/C7), CD25-AF700 (M-A251), CD4-APCH7 (RPA-T4), CXCR5-AF647
(RF8.B2), CD45RA-PECF594 (HI100), CD19-APCCy7 (SJ25C1), IgM-FITC (G20-127),
IgD-PECF594 (IA6-2), CD38-V450 (HB7), CD138-PerCPCy5.5 (MI15), CD21-APC (B-LY4),
CD27-PE (M-T271), IgG-BV605 (G18-145) or BioLegend (San Diego, CA, USA): PD1-PE
(EH12.2H7), CD19-BV650 (HIB19), CD57-PB (HCD57), ICOS-FITC and ICOS-PerCPCy5.5
(C398.4A), OX40-PECy7 (BER-ACT35), CD40L-BV605 (24–31).
Membrane staining. Cells were washed twice with PBS1X containing 0.5% BSA and 2mM
EDTA, pre-incubated 5 minutes at room temperature with anti-CXCR5 and anti-CCR7 anti-
bodies and then stained for 20 minutes at room temperature with the corresponding mix of
conjugated antibodies.
Intracellular Foxp3 staining. Cells were washed and permeabilized using Human Foxp3
Buffer Set (BD Biosciences) according to the manufacturer’s recommendation and stained for
30 minutes at room temperature with antibody Foxp3-AF488 (259D/C7) from BD Biosciences.
Cell acquisition was performed with a Fortessa cytometer (BD Biosciences) and data was
analyzed with BD FACSDiva software (BD Biosciences) or FlowJo (Tree Star, Ashland, OR,
USA).
Assessment of integrated proviral DNA using qRT-PCR
A fraction of the naive, memory, Tfh and GCTfh CD4 cells sorted from infected spleens were
reserved and conserved at -80°C in RNA later (Qiagen). Proviral integration was assessed by
quantitative real-time PCR (qRT-PCR) for HIV-gag DNA, as previously described [32].
Fluidigm Gene Expression analysis
Cell sorting and reverse transcription. Splenocytes from 5 HIV+ITP+ and 4 HIV-ITP-
patients were thawed and stained with the “Tfh sorting” panel (S2 Fig).
One hundred cells of each population were collected by FACS sorting using a FACSAria II
(BD Biosciences) in a RT-PreAmplification Reaction mix containing the pooled TaqMan prim-
ers (0.2X of each) and the SuperScriptIII Platinium Taq Polymerase from the CellDirect One-
Step qRT-PCR Kit (Invitrogen). Reverse transcription and gene-specific pre-amplification
were performed (18 cycles). cDNA was diluted 1/5 in DNA suspension buffer (Teknova), and
stored at 4°C.
Fluidigm dynamic array. Samples and assays (primer pairs) were prepared for 96.96 Flui-
digm Dynamic arrays (Fluidigm, San Fransisco, CA, USA) according to the manufacturer’s
recommendation. Briefly, assays were prepared by dispensing 20X Fluidigm Gene Expression
assay Loading Reagent and the matching 20X TaqMan Gene Expression Assay into the wells of
Splenic Tfh Subsets in HIV-1 Infection
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a 10X Assay Plate. Samples were mixed with 20X Fluidigm Sample Loading Reagent and Taq-
Man Universal PCR Master Mix 2X (Applied Biosystems). A 96.96 Dynamic Array primed
chip was then loaded with assays and samples, and the real time-PCR was run on a Biomark
System for Genetic Analysis according to the Fluidigm Protocol. All reactions were made in
duplicate. Data were collected and analyzed using Fluidigm Real-Time PCR Analysis software.
Multivariate analysis. Multivariate analysis allows for the simultaneous consideration of
all investigated genes, for the identification of genes that contributed most to the total variance
between HIV+ and control samples. SAS-JMP software version 10.0.0 (SAS Institute Inc.,
Cary, NC, USA) was used for multivariate analysis: Principal component Analysis and unsu-
pervised hierarchical clustering (S3 Fig).
Statistics
Statistical significance (p-values) was obtained using the non parametric Mann-Whitney U
test. p<0.05, p<0.005, p<0.001. Error bars depict mean +/- standard error of the mean
(SEM) in all bar graphs shown. The GraphPad Prism statistical analysis program (Graph-Pad
Software, version 5.0) was used throughout.
Results
Impact of chronic HIV infection on CD4 T and B cell distribution in the
spleen
Using flow cytometry, we evaluated the impact of HIV infection on the distribution of CD4 T
cell subsets and B cell maturation in splenocytes. Spleen samples consisted of 4 groups includ-
ing HIV negative ITP negative (HIV-ITP-) (n = 7), HIV-ITP+ (n = 3), HIV+ITP- (n = 4), HIV+-
ITP+ donors (n = 8). All HIV+ spleens came from individuals classified in the chronic stage
(from middle to late stage) of HIV infection who did not receive HAART.
First, we investigated the distribution of CD4 T cells among naïve, central memory (TCM),
effector memory (TEM), terminally differentiated effector memory cells with reacquired
CD45RA (the marker of naïve cells) (TEMRA) and regulatory T cell (Treg) (Fig 1A). Propor-
tions of naïve, TCM TEM and TEMRA CD4 T cell subsets were not affected by HIV infection.
Interestingly, HIV+ spleens exhibited a slight increase of the Treg population, while this popu-
lation was decreased (p<0.05) in HIV-ITP+ spleens, as compared to HIV- ITP- spleens (Fig
1A).
We then focused on the follicular helper T cell populations (Fig 1B and S1 Fig). We identi-
fied splenic Tfh cells as memory T helper cell expressing CXCR5high PD-1high but not CCR7.
CD57 expression was used to characterize GCTfh [33] (S1 Fig). We observed that the percent-
ages of Tfh and GCTfh cells were significantly increased among memory CD4 T cells (Fig 1B).
Overall, this increase is strictly restricted to HIV+ individuals independently of their ITP sta-
tus. HIV+ITP- samples exhibit a significant increase of Tfh cell (p = 0.0141) and of the GCTFh
cell (p = 0.0131) frequencies, as compared to HIV-ITP-, whereas we observed no significant dif-
ferences between HIV-ITP- and HIV-ITP+ samples. Of note, Tfh and GCTfh cell frequencies
were similar between HIV+ITP- and HIV+ITP+ samples (not shown) confirming that the ITP
status does not impact Tfh cells distribution in these samples.
We also analyzed the Tfr cell population, the regulatory counterpart of Tfh cells, within the
spleens (Fig 1B). Tfr express all the characteristic markers of Tfh, as well as Foxp3 and CD25
markers (S1 Fig). Remarkably, the proportion of Tfr among memory CD4 T cells was signifi-
cantly increased in HIV+ splenocytes as compared to HIV-ITP- and HIV-ITP+ individuals (Fig
1B).
Splenic Tfh Subsets in HIV-1 Infection
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We then asked whether Tfh and Tfr cell expansions might be associated, in the spleens, with
alterations of the B cell compartment. To this end we used flow cytometry, to characterize the
different stages of differentiation from naïve B cells to memory B cells and antibody-secreting
plasma cells [34] (S1 Fig). The percentage of naive B cells, defined as Bm1 and Bm2 popula-
tions among total B cells (S1 Fig), was comparable in HIV-infected spleens as compared with
uninfected (Fig 2A). In contrast, the percentages of the pre-GC and GC B cells, defined as
Bm2’ and Bm3/4 respectively (S1 Fig) were significantly increased in both HIV+ITP- and HIV-
+ITP+ samples (Fig 2A). In addition, in the context of HIV-infected spleens, the ratio of mem-
ory B cells, defined as early Bm5 and late Bm5 was decreased, independently of the ITP status
Fig 1. Tfh cell subsets, including Tfr, are present in greater proportions in HIV+ spleens. (A) Splenocytes were stained for T helper cell markers and
analyzed by flow cytometry: according to the expression of CD45RA and CCR7, CD4 T cells were subdivided into CD45RA+CCR7+ naïve, CD45RA-CCR7-
effector memory (TEM), CD45RA+CCR7- terminally differentiated effector memory (TEMRA) and CD45RA-CCR7+ central memory (TCM) T cells. Regulatory
T (Treg) cells were identified as CD4+ CD45RA- Foxp3+ CD25+. HIV-ITP- n = 8, HIV+ITP- n = 4, HIV-ITP+ n = 3 and HIV+ITP+ n = 9. (B) Tfh cells were
identified as CD3+ CD4+ CD45RA- CCR7- CXCR5+, GCTfh are the CD57+ subset of Tfh, and Tfr are Foxp3+ Tfh cells (S1 Fig). The frequency of Tfh, GCTfh
and Tfr cells is represented as the percentage of total memory CD4+ T cells. HIV-ITP- n = 8, HIV+ITP- n = 4, HIV-ITP+ n = 3 and HIV+ITP+ n = 9. Frequency of
Treg and Foxp3+ Tfh (Tfr) were identified for HIV-ITP- n = 4, HIV-ITP+ n = 3, HIV+ITP- n = 3 and HIV+ITP+ n = 4. Statistics were obtained using the non
parametric Mann-Whitney test *p<0.05, **p<0.005, ***p<0.001.
doi:10.1371/journal.pone.0140978.g001
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Fig 2. GC B cells accumulate whereasmemory B cell compartment is reduced in HIV+ spleens. (A) Using flow cytometry, B cell maturation was
assessed according to the expression of CD38 and IgD markers by CD19+ cells (34). The gating strategy is presented in S1 Fig. In HIV chronically infected
patients, B cell maturation is biased towards GC B cells and PC subsets as compared to HIV- donors and ITP+ patients. (B) The transitional B cell population
was identified as CD19+CD38++IgD+CD27-IgM+ and plasma cells as CD19+CD38++IgD-. In the box-and-whiskers plot, box size represents the limits of data
for the second and third quartiles, with medians shown as bars. Whiskers define the minimum and maximum of the data presented. HIV-ITP- n = 8, HIV-ITP+
n = 3, HIV+ITP- n = 5 and HIV+ITP+ n = 8. Statistics were obtained using the non parametric Mann-Whitney test *p<0.05, **p<0.005, ***p<0.001.
doi:10.1371/journal.pone.0140978.g002
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(Fig 2A). Remarkably, transitional B cells (CD19+CD38++IgD+CD27-IgM+) were significantly
increased in HIV+ spleens as compared to HIV-ITP- and HIV-ITP+ samples (Fig 2B). Plasma
cells (CD19+CD38++IgD-) were also slightly increased in HIV+ spleens (Fig 2B).
Altogether our data unravel that Tfh cell subsets, including Tfr, are present in greater pro-
portions in HIV+ spleens. Pre-GC and GC B cells also accumulate in the spleen while further
differentiation is rerouted to plasma cells at the cost of memory B cell differentiation as already
reported in lymph nodes by Lindqvist et al. [14].
Transcriptional profiles of splenic Tfh and GCTfh cells
Recent studies performed with the blood or lymph nodes of HIV-infected donors, suggested
that Tfh cells might be functionally altered as compared to Tfh from uninfected individuals
[13,14]. We therefore investigated some functional attributes of Tfh from the spleen. To this
end, we performed a comparative transcription profile analysis between Tfh and GCTfh from
chronically HIV+ and HIV- spleens. Expansion of splenic Tfh and GCTfh cells is restricted to
HIV+ individuals independently of their ITP status (Fig 1B). Thereafter and because of the
scarcity of spleen samples from HIV+ITP- donors, we performed the transcriptome analysis on
HIV+ITP+ samples. GCTfh and Tfh were isolated by cell sorting based on the expression of
CXCR5 and PD-1 markers. GCTfh cells express the CD57 marker that allows their identifica-
tion. S2 Fig shows the gating strategy used to sort splenic Tfh and GCTfh from 4 HIV-ITP-
(A-D) and 5 HIV+ITP+ (F-J) donors. Sorted cells were used to perform high throughput gene
expression measurement with real time PCR in a microfluidic dynamic array. Using this
approach, we quantified the expression of 96 genes of interest in 100 cells. After cleansing and
normalization, consistent data were used for statistical analysis. We focused on genes specifi-
cally implicated in T cell functions (S1 Table).
First, using JMP statistical software, we performed a principal component analysis (PCA) to
reduce the multidimensional gene expression data set to lower dimensions for analysis, by
retaining genes that contributed most to the total variance (Fig 3A). The projection of the data
on the first component (38.3% variance explained) efficiently discriminated HIV+ samples,
suggesting that HIV infection deeply impacts gene expression profile of Tfh and GCTfh cells
(Fig 3A, Top panel). Particularly, component 1 revealed a bias of Tfh from HIV+ spleens to
preferentially express genes implicated into Tfh cell differentiation and Th1 functions whereas
Tfh from HIV- spleens more highly expressed genes implicated in costimulation, inhibition
and signal transduction functions (Fig 3A, lower panel and S1 Table).
Genes displaying significant differences in their expression levels between Tfh cells from
HIV+ and HIV- donors are presented in Fig 3B. Gene expression levels between Tfh and
GCTfh cells were similar except in two cases: in HIV- samples, CXCL13 gene expression was
significantly enhanced in GCTfh samples as compared to Tfh and in HIV+ samples, IL-10 was
greatly impaired in Tfh as compared to GCTfh. Remarkably, the expression levels of genes
implicated in Tfh differentiation such as BCL6, BATF, andMAF were not affected by HIV
infection, appearing slightly increased in Tfh and GCTfh from HIV+ samples (Fig 3B), while
IL-21 and CXCL13 expression, two key mediators of Tfh function, were increased in Tfh from
HIV+ spleens. In contrast, the expression level of signal transducer and activator of transcrip-
tion (STAT)-3 gene, which is required for full Tfh differentiation [35] was significantly reduced
in Tfh and GCTfh from HIV+ spleens as compared to HIV- samples. In addition, HIV infection
significantly compromised the expression of the costimulatory molecules OX40 (TNFRSF4),
CD40L and, to a lesser extent, ICOS encoding genes, in both Tfh and GCTfh. Very interest-
ingly, the expression of genes encoding immune regulatory molecules such as IL-10, CTLA4
and PD-1 was also severely impacted by HIV infection in both Tfh and in GCTfh. Of note, the
Splenic Tfh Subsets in HIV-1 Infection
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expression of the proliferation marker Ki67 mRNA was also notably reduced. Finally, our
results indicated that gene encoding SLAMF1 and CD48 receptors that belong to the family of
the Signaling lymphocytic activation molecule (SLAM) are significantly impacted by HIV
infection. Of note, SLAMF1 is specifically required for IL-4 production by GCTfh [36]. In con-
trast, the expression of SLAM-associated protein (SAP), known to play a critical role in the sus-
tained adhesion between T and cognate B cell [37,38] is not compromised by HIV-infection. In
conclusion in HIV+ spleens, the expression of most genes implicated in Tfh and GCTfh differ-
entiation was not compromised with the notable exception of STAT-3 suggesting that only the
final stage of Tfh differentiation might be affected by HIV-infection. In contrast, the expression
of genes implicated in Tfh function, such as costimulation, immune regulation or signal trans-
duction were severely reduced in HIV-infected spleens.
Unsupervised hierarchical clustering grouped together GCTfh from HIV+ samples (S3 Fig).
Hence, CXCL13, IL-21, and CXCR5 genes were highly expressed in GCTfh cells from HIV+
samples as well as those encoding transcription factors implicated in Tfh differentiation (MAF,
BATF, Bcl6). These observations might explain the higher proportion of GCTfh in HIV+
spleens.
Ex-vivo cytokine production by splenocytes
To evaluate whether our observations on the skewed transcription profiles of Tfh cells might
modulate the splenic microenvironment we analyzed ex vivo the capacity of activated spleno-
cytes to secrete various cytokines. This question could not be addressed directly using Tfh cells
since their low frequency in HIV- spleens did not allow their sorting and assessement of func-
tional properties such as cytokine secretions. Thereafter, cytokine secretion profiles were evalu-
ated using whole splenocytes.
To this end, splenocytes from HIV-ITP- (n = 4), HIV-ITP+ (n = 3), HIV+ITP- (n = 4) and
HIV+ITP+ (n = 5) were activated using PHA and secretion of IL-10, IL-4, Il-6 and IL-1ß were
quantified (Fig 4).
We observed a profound defect of HIV+ splenocytes to produce IL-10 and IL-4, two major
cytokines produced by Tfh cells and related to B cell maturation. This observation is restricted
to HIV+ samples independently of the ITP status since no significant difference was observed
when comparing ITP- and ITP+ samples (not shown). Strikingly, IL-6 and IL-1ß productions
were not affected by HIV-infection (Fig 4). IL-6 secretion is classically linked to viral infection.
However Shive et al. have demonstrated that IL-6 secretion is not correlated with HIV-RNA.
Moreover, histoculture of HIV chronically infected lymph nodes as well as histoculture of
HIV- lymph nodes in vitro infected with HIV do not reveal any difference in the amount of IL-
6 secretion as compared to control lymph nodes [39].
Fig 3. HIV infection severely impacts transcription profile of splenic Tfh and GCTfh cells.GCTfh and Tfh were sorted using flow cytometry based on
the expression of CXCR5 and PD-1 associated or not with CD57 marker respectively (S2 Fig). Sorted cells were used to perform high throughput gene
expression measurement with real time PCR in a microfluidic dynamic array. After cleansing and normalization, consistent data were used for statistical
analysis. We focused on genes specifically implicated in T cell functions (S1 Table). (A) 2D Principal component analysis (PCA) plot representation of gene
expression profile of Tfh (triangle) and GCTfh (diamond) cells from HIV- ITP- (n = 4, empty symbols) and HIV+ ITP+ (n = 5, filled symbols) spleens. The
projection of the data on the first and second principal components efficiently discriminates HIV+ samples, suggesting that HIV-infection deeply impacts gene
expression profile of Tfh and GCTfh cells. (B) mRNA expression in Tfh and GCTfh sorted from splenocytes of uninfected (n = 4) and HIV+ (n = 5) individuals.
The data are expressed in 40-Ct where Ct represents the threshold cycle number and 40 is chosen because the PCR run stops after 40 cycles. This value is
directly correlated with the initial amount of RNA and therefore allows a quantitative comparison for 18 genes encoding cytokines/chemokines and proteins
implicated in Tfh differentiation, costimulation, immune regulation and signal transduction. Statistics were obtained using the non parametric Mann-Whitney
test *p<0.05, **p<0.005, ***p<0.001.
doi:10.1371/journal.pone.0140978.g003
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Thus, our results demonstrated a defective IL-10 and IL-4 production by activated spleno-
cytes and provided new evidence to explain both defective B cell differentiation and Tfh cells
abundance observed in HIV+ individuals.
HIV-1 DNA integration in splenic Tfh cells
CD4+ T cells being the major target for HIV infection, we then asked whether HIV might
infect splenic Tfh cells. To address this question, we sorted CD3+CD4+CD45RA+ naïve, CD3+-
CD4+CD45RA-ICOS- resting memory, and CD3+CD4+CD45RA-ICOS+PD-1highCXCR5+ total
Tfh CD4 T cell populations from chronically HIV+ subjects (HIV+ITP+ n = 5) and quantified
Fig 4. Activated HIV+ splenocytes fail to produce IL-4 and IL-10: Total splenocytes were stimulated with PHA for 2 days and culture supernatants
were analyzed for IL-1ß, IL-6, Il-4 and IL-10 using enhanced sensitivity BD CBA flex set assay. Horizontal bars represent mean and error bars show
SEM. HIV-ITP- n = 4, HIV-ITP+ n = 3, HIV+ITP- n = 4 and HIV+ITP+ n = 5. Statistics were obtained using the non parametric Mann-Whitney test *p<0.05,
**p<0.005, ***p<0.001.
doi:10.1371/journal.pone.0140978.g004
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integrated HIV proviral genomes (Fig 5). HIV proviral DNA copy numbers were normalized
to genomic DNA input (Fig 5).
Our results indicated that whereas resting memory CD4 T cell populations harbored only a
slightly higher amount of HIV-DNA copies than naïve CD4T cells, the Tfh subset harbored a
significantly higher amount of HIV DNA (more than 4-fold increase). Our data obtained using
HIV-infected spleens are in accordance with observations using lymph nodes [13]. This raises
an apparent paradox between the elevated proportions of Tfh cells population and their acti-
vated status and their higher susceptibility to HIV integration.
Discussion
The recent discovery of broad and potent HIV-1 neutralizing antibodies (bNAbs) has renewed
optimism for developing an effective vaccine against HIV-1 [40]. The generation of bNAbs
requires multiple rounds of B cell receptor (BcR) affinity maturation, suggesting a crucial role
of Tfh in their generation [41]. However, less than 1% of HIV-infected patients develop bNAbs
that arise late in the infection, 2 to 4 years after infection, indicating probable Tfh and B cell
dysfunctions in HIV infection [42].
Fig 5. Splenic Tfh subset harbor high amount of HIV-1 DNA integration. qRT-PCR quantification of HIV
proviral DNA levels in GCTfh, Tfh, memory and naïve CD4+ T cell subsets isolated from splenocytes of five
HIV+ ITP+ individuals as described in S1 Fig. Symbols represent individual samples: horizontal bars
represent mean; and error bars show SEM. Statistics were obtained using the non parametric Mann-Whitney
test *p<0.05, **p<0.005, ***p<0.001.
doi:10.1371/journal.pone.0140978.g005
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Until now, most studies have investigated human Tfh subsets in lymph nodes of HIV-
infected patients [13,14,17]. However, spleen constitutes another major compartment for the
induction of adaptive immunity against blood borne pathogens such as HIV. Here, using a
unique collection of cryopreserved spleens cells from HIV-infected individuals, we performed
an extensive characterization of Tfh, GCTfh and Tfr cells. Similar to what has been already
reported in lymph nodes, the percentages of Tfh and GCTfh cells were significantly increased
in HIV+ spleens, while ITP status did not impact these populations. We also reported a slight
increased Foxp3+ Treg population in accordance with reports of highly elevated Treg levels in
mucosa of untreated chronically HIV+ patients [43]. For the first time we showed that Tfr pro-
portions were significantly increased in HIV+ spleens. These results suggest that the expansion
of Tfh and GCTfh populations might not result from a scarcity in Tfr cells, as suggested in
HIV-ITP+ spleen samples studies [44]. The question of Tfr suppressive functions would be
very interesting to address in those samples. However due to the lack of specific cell surface
markers identifying Tfr, splenic Tfr cells could not be sorted and tested for their suppressive
function on Tfh proliferation. Moreover, since the development of Tfr cells kinetically follows
Tfh amplification in order to regulate the GC reaction [10] one can hypothesize that the GC
reaction is sustained but not completed in chronically HIV+ spleens.
HIV infection impairs B cell maturation causing a loss of memory B cell and an expansion
of plasma cells [13,14,18,19,45]. Of note, loss of memory B cells during HIV infection is also
due to apoptosis [46]. Here, we reported a skewed B cell distribution in HIV+ spleens: pre-GC
and GC B cells accumulated while further differentiation was rerouted to plasma cells at the
cost of memory B cell differentiation. The loss of memory B cells has already been noted in the
spleens from SIV-infected macaques [47]. Hence, although increased in HIV+ spleens, Tfh and
GCTfh populations were not able to support complete B cell differentiation from naïve to
memory phenotype. Remarkably, excessive numbers of Tfh cells can result in B cells losing
their affinity for antigen or even becoming self-reactive [48]. In line with this, it has been
shown that splenic Tfh expansion participates in anti-platelet-antibody production in ITP [49].
In our collection of HIV- ITP+ samples, we did not observe enrichment in Tfh cells as com-
pared to HIV- ITP-, further highlighting that the increase of Tfh cells in HIV+ samples is most
likely a consequence of HIV-infection. Many autoimmune disorders, such as ITP, have been
shown to have a higher incidence among HIV+ individuals [50]. Of note, a recent study
reported the characterization of an anti ds-DNA antibody that also broadly neutralizes HIV in
a SLE/HIV individual [51].
Perreau et al. have already shown that Tfh cells serve as a major CD4 T cell compartment
for HIV infection, replication and production in lymph nodes from viremic HIV+ patients
[13]. Consistent with their data, we reported a higher amount of HIV-1 DNA integration in
total splenic Tfh cell populations than in naïve and resting memory CD4 T cells. However,
according to the phenotypic characterization of ex vivo splenic CD4 T cell populations, Tfh
cells were in higher proportion in HIV+ individuals. This raises an apparent contradiction
between the elevated proportions of Tfh cells and their higher susceptibility to HIV infection.
One possible explanation is that antigen persistence could drive CD4 T cells away from antivi-
ral Th1 toward Tfh differentiation [52]. Hence, one can hypothesize that untreated patients in
chronic stage of HIV infection present high amounts of viral antigens leading to an exacerbated
Tfh differentiation. Interestingly, HIV particles are associated to GC follicular dendritic cells in
tonsils and lymph nodes from infected patients [53–55] and Cheynier et al. reported persis-
tence of high level of HIV particles in GC of HIV+ spleens from untreated subjects [24]. Thus,
antigen persistence combined with immune activation could explain Tfh (and Tfr) expansion
despite their higher susceptibility to HIV-integration. In contrast to what reported by Perreau
et al. [13], we found that Ki67 mRNA expression was significantly lower in Tfh and GCTfh
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from HIV+ samples than in HIV- samples. However, in accordance with our results, Petrovas
et al. reported that higher Ki67 expression by Tfh cells is restricted to the acute phase and is not
observed at the chronic stage of SIV infection [15].
This suggests that the higher proportion of Tfh cells was most likely due to a bias towards
Tfh differentiation rather than to higher proliferative capacities. Another, non exclusive expla-
nation is that Tfh cells may display restriction factors that are specific or more abundant than
in other CD4+ T cells, allowing persistent HIV infection and integration with low
proliferation.
The cytokine / chemokine environment might also promote Tfh cells differentiation and
their homing into GC [1]. In this study, we showed that expression of IL-21 and CXCL13
encoding genes was enhanced in Tfh from HIV+ samples, suggesting that Tfh cells differentiat-
ing during HIV infection can contribute to a suitable signaling milieu for GC development.
The key role of Tfh cells is to provide strong B cell helper signals and therefore promote
their differentiation into memory B cell displaying high affinity for pathogens. This signal con-
sists of cytokines such as IL-4 and IL-21 and of cell surface molecules such as ICOS and CD40L
[1]. Despite the large proportion of follicular T cell subsets in HIV+ spleens, gene expression
profiling suggested that both Tfh and GCTfh cells were compromised in their capacity to pro-
vide strong co-stimulatory signals. CD40L down modulation as been described in total CD4T
cell population in late stages of HIV infection [56]. Our transcriptome data using Tfh are in
accordance with these observations.
The expression of SLAMmolecules was also severely impacted. Combined together, these
defects will impact the long lasting T cell / B cell cognate interaction required for the full B cell
differentiation into long-lived plasma cells. Very interestingly, SLAMF1 is specifically required
for IL-4 production by GCTfh [36], which underlines its major role in GC homeostasis. Hence,
our data indicated a defect in SLAMF1 gene expression that might explain the low level of IL-4
production observed in those spleens. Since IL-4 is one of the major cytokines secreted by Tfh
[57] and is required for optimal humoral responses, low IL-4 production displayed by HIV+
spleens might contribute to defective GC reaction.
As suggested by our gene expression analysis, IL-10 production was severely compromised
in HIV+ spleens. Considering that IL-10 is a potent B cell differentiation factor, low level of IL-
10 production might contribute to the defective B cell maturation into memory B cells in HIV+
spleens. Moreover, IL-10 is a key component of immune regulation in addition to PD-1 and
CTLA-4. Here we identified an impaired expression of these inhibitory receptors in the total
Tfh population. Interestingly, in addition to PD-1/PD-L1 interactions [17], recent studies
reported the major role of the coinhibitory CTLA-4 receptor in the control of the GC reaction
by modulating Tfh, Tfr and Treg [58–60]. Therefore, defective expression of IL-10, PD-1 and
CTLA-4 might also lead to uncontrolled GC reaction and support Tfh and GCTfh cell differen-
tiation observed in HIV+ spleens.
In the context of HIV-infection, the defective STAT-3 encoding gene expression reported
here is also of particular interest since it should impact on the full polarization of Tfh. Hence,
following acute viral infection, STAT-3 has been reported to repress Type I interferons to pro-
mote Tfh cell differentiation, at the cost of Th1 polarization [61]. Therefore, defective STAT-3
expression might explain why Tfh from HIV+ spleens harbored a transcription profile biased
toward Th1 functions.
Some limitations of the present study should be addressed. First, most of our findings are
based on transcriptome profile analysis of sorted Tfh and GCTFh cells and are not confirmed
at the level of the protein expression because of the low numbers of cells. Of note, whereas Bcl6
mRNA quantification is not predictive for Bcl6 protein expression [62], STAT-3, CXCR5,
CXCL13, IL-4, IL-21, CTLA4 and Il-10 mRNA quantifications have been reported to correlate
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with the protein levels and most of theses transcripts are biomarkers of pathogenic processes in
oncology and transplantation [63–68]. Second, the number of samples is relatively small, nota-
bly for HIV+ITP- samples. By comparing HIV-ITP- with HIV-ITP+ and HIV+ITP- with HIV+-
ITP+, we found that ITP status does impact the frequency of Tfh and GCTfh cell populations
(not shown). We also verify that IL-4 and IL-10 secretions are not driven by ITP status. These
verifications allowed us to combine samples ITP+ samples with ITP- in our analysis and reach
the sample size that allows statistical significance.
In sum, using unique samples obtained from chronically HIV-infected individuals, we char-
acterized splenic Tfh, GCTfh, and Tfr cells subsets. To our knowledge, this study constitutes
the first characterization of Tfh populations, including regulatory cells, in spleen that is the
largest lymphoid organ and where the adaptive immune response against blood-borne antigens
takes place. We observed that HIV infection leads to a higher proportion of Tfh cells in the
spleen as well as a global increase of natural regulatory T and Tfr cells. Remarkably, chronic
HIV-infection severely impacted the transcription profile of splenic Tfh and GCTfh, particu-
larly affecting expression of genes implicated in costimulation, inhibition and signal transduc-
tion. Moreover, upon activation, the production of IL-4 and IL-10 was severely compromised
in HIV+ spleens. These multiple failures displayed by Tfh cells and splenocytes from HIV+
individuals most likely contributed to impair B cell maturation and differentiation. Indeed in
HIV-infected spleens, pre-GC and GC B cells accumulated while further differentiation was re-
routed toward plasma cells at the cost of memory B cell differentiation. This skewed B cell dif-
ferentiation might strongly impact the capacity of the immune system to generate bNAbs.
Altogether, our work provides new insights in HIV pathogenesis and explains the global defec-
tive humoral responses observed in chronically HIV+ patients.
Supporting Information
S1 Fig. Representative flow cytometry contour plots (A) Phenotypic analysis of CXCR5high
CCR7low memory CD4 T cells in splenocytes from HIV-infected individuals. Gating strat-
egy used to identify total Tfh, Tfh, GCTfh and Tfr is shown. (B) Representative flow cytom-
etry contour plots showing the B cell maturation for HIV- ITP-, HIV- ITP+, HIV+ ITP- and
HIV+ ITP+ individuals. Bm1 (naïve) CD38-IgD+, Bm2 (activated naive) CD38-IgD++, Bm2’
(pregerminal center) CD38++IgD+, Bm3/4 (germinal center) CD38++IgD-, early Bm5 CD38
+IgD-, late Bm5 (CD38-IgD-), and plasma cells (PC) CD38+++IgD- proportions were deter-
mined among CD19+ cells.
(TIF)
S2 Fig. Gating strategy used to sort Tfh and GCTfh from healthy (n = 4) and HIV+ ITP+
spleens (n = 5). Sorted cells were used for transcriptome profile analysis (Fluidigm assay).
(TIF)
S3 Fig. Unsupervised hierarchical clustering using ward clustering method of 17 selected
genes reported to play key roles in Tfh functions: HIV- ITP- (n = 4, A-D) HIV+ ITP+ (n = 5,
F-J). Gene expression has been quantified using the Fluidigm technology in Tfh and GCTfh
populations. As compared to healthy controls (green square), Tfh and GCTfh from HIV+ sam-
ples display a down-modulation of both costimulatory (TNFRSF4, ICOS, CD40LG) and regu-
latory molecules (CTLA-4, PD-1, IL-10). Expression of genes implicated in signal transduction
(CD48 and SLAMF1) is also impaired in HIV+ samples. Tfh and GCTfh cells from HIV+ sam-
ples highly express genes implicated in Tfh associated functions (CXCL13, IL-21, CXCR5) and
genes encoding transcription factors implicated in Tfh differentiation (MAF, BATF, Bcl6) (red
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square).
(TIF)
S1 Table. Name and function of genes associated with T helper function and differentia-
tion.
(TIF)
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